Eckert & Ziegler: new production location in Warsaw being planned
Eckert & Ziegler to become the long-term contrast agent supplier to leading Polish clinic chain
Advertisement
Eckert & Ziegler Strahlen- und Medizintechnik AG has concluded a long-term contract with Euromedic International B.V., based in Budapest, to supply Polish diagnostics centres. The framework agreement for so-called FDG (Fluorodeoxyglucose (18 F)) also envisages the creation of a pharmaceutical production facility in Warsaw in addition to the FDG supply.
Eckert & Ziegler radiopharmacy Director, Dr. André Heß and Axel Schmidt, Managing Director of the group subsidiary Eckert & Ziegler f-con Deutschland GmbH that manages the project, declared in a joint statement: "Euromedic is a strategic partner with whom we have already been successfully cooperating for many years. We support the further expansion of the Polish cancer treatment centres with the creation of a new radiodiagnostics production plant near Warsaw and are looking forward to closer cooperation with Euromedic. It enables us to further expand our industry leadership in Germany to Eastern Europe."
FDG will be used within the framework of positron emission tomography (PET) for the safe and early detection of even the smallest tumor foci. As a result of its short half-life, FDG has to be produced daily on locally cited cyclotrons and delivered to the clinics as soon as possible. Eckert & Ziegler currently supplies a host of Polish PET-CT centres from its production facility in Berlin.
Other news from the department manufacturing
